International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)
Asia-Pacific Journal of Ophthalmology · 2025
DOI: 10.1016/j.apjo.2025.100252 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2025. Verfasst von Nishant V Radke und 25 weiteren Autor:innen. Beteiligte Einrichtung: The Primasia International Eye Research Institute of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China; Eye Department, C+ Health CKJ (…. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Societies, Medical, Ophthalmology, Practice Guidelines as Topic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese University of Hong Kong.
Abstract (Originalsprache)
PURPOSE: To establish consensus-based guidelines on the diagnosis, classification, and management of central serous chorioretinopathy (CSC) through a structured expert panel initiated by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), and the Academia Retina Internationalis (ARI), addressing the existing clinical controversies. METHODS: An international panel of 26 experts from 13 countries collaboratively drafted consensus statements spanning five key areas: disease definition, pathophysiology, investigations, current management, and future developments. Consensus was reached through an iterative Delphi process and anonymous voting using a five-point Likert scale. Statements were accepted when >75 % agreement ('agree' & 'strongly agree') was achieved. RESULTS: Consensus was achieved for all 25 statements, reflecting strong alignment among experts. Key agreements included defining CSC as a pachychoroid-driven chorioretinal disorder characterized by neurosensory retinal and/or RPE detachment, with multimodal imaging (optical coherence tomography, fundus autofluorescence, fluorescein angiography, and indocyanine green angiography) recognized as essential for diagnosis. Half-dose photodynamic therapy (PDT) was unanimously endorsed as the first-line treatment for chronic CSC. Oral mineralocorticoid receptor antagonists (MRAs) lacked consensus for therapeutic benefit, aligning with evidence from the VICI and SPECTRA trials. Anti-vascular endothelial growth factor receptor therapy was recommended solely for CSC complicated by a macular neovascularization. Future priorities highlighted standardizing disease classification and exploring targeted therapies through genetic and nanomedicine research. CONCLUSION: This consensus initiative provides a robust, evidence-based framework for the diagnosis and management of CSC, promoting standardization across clinical practices and guiding future research directions to address persistent gaps in CSC care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Primasia International Eye Research Institute of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China; Eye Department, C+ Health CKJ (Shenzhen) Hospital, Luohu, Shenzhen, China; The C-MER (Shenzhen) Denni…
- Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; Rotterdam Eye Hospital, Rotterdam, the Netherlands.
- Vitreous Retina Macula Consultants of New York, New York, NY, USA.
- Department of Ophthalmology, University of Bonn, Bonn, Germany.
- Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus, Ginowan, Okinawa, Japan.
- Vitreous Retina Macula Consultants of New York, New York, NY, USA; Department of Ophthalmology, New York University Grossman School of Medicine, New York, NY, USA.
Förderung
- Chinese University of Hong Kong
Zitieren
APA
Radke, N. V., van Dijk, E. H. C., Spaide, R. F., Holz, F. G., Koizumi, H., Freund, K. B., Subhi, Y., Lange, C., Singh, S. R., Chen, H., Chen, L. J., Chen, S. N., Chhablani, J., Behar-Cohen, F., Das, T., Fung, A. T., Gomi, F., Kim, M., Lai, C. C., …, & Boon, C. J. F. (2025). International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI). Asia-Pacific Journal of Ophthalmology. https://doi.org/10.1016/j.apjo.2025.100252
Vancouver
Radke NV, van Dijk EHC, Spaide RF, Holz FG, Koizumi H, Freund KB, et al. International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI). Asia-Pacific Journal of Ophthalmology. 2025. doi:10.1016/j.apjo.2025.100252
BibTeX
@article{Radke2025,
author = {Radke, Nishant V and van Dijk, Elon H C and Spaide, Richard F and Holz, Frank G and Koizumi, Hideki and Freund, K Bailey and Subhi, Yousif and Lange, Clemens and Singh, Sumit Randhir and Chen, Haoyu and Chen, Li Jia and Chen, San-Ni and Chhablani, Jay and Behar-Cohen, Francine and Das, Taraprasad and Fung, Adrian T and Gomi, Fumi and Kim, Min and Lai, Chi-Chun and Lai, Timothy Y Y and Lee, Christopher Seungkyu and Lotery, Andrew and Sivaprasad, Sobha and Zhao, Mingwei and Lam, Dennis S C and Boon, Camiel J F},
title = {International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2025},
doi = {10.1016/j.apjo.2025.100252}
}
EUVIMED